It was also shown that treatment with BAFF-R-Fc did not have any significant inhibitory effect on myeloma cell growth, implying that blockade of APRIL is more beneficial than the blockade of BAFF for MM patients. Here, TNFRSF13C is linked to plasma cell myeloma.